DK431589D0 - Saarbehandlingsmidler indeholdende thromboxan a2-receptor-antagonister - Google Patents

Saarbehandlingsmidler indeholdende thromboxan a2-receptor-antagonister

Info

Publication number
DK431589D0
DK431589D0 DK431589A DK431589A DK431589D0 DK 431589 D0 DK431589 D0 DK 431589D0 DK 431589 A DK431589 A DK 431589A DK 431589 A DK431589 A DK 431589A DK 431589 D0 DK431589 D0 DK 431589D0
Authority
DK
Denmark
Prior art keywords
thromboxan
spare
receptor antagonists
treatments containing
treatments
Prior art date
Application number
DK431589A
Other languages
English (en)
Other versions
DK431589A (da
DK175207B1 (da
Inventor
Lawrence T Friedhoff
Laura L Bolton
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of DK431589D0 publication Critical patent/DK431589D0/da
Publication of DK431589A publication Critical patent/DK431589A/da
Application granted granted Critical
Publication of DK175207B1 publication Critical patent/DK175207B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Financial Or Insurance-Related Operations Such As Payment And Settlement (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
DK198904315A 1988-09-01 1989-08-31 Sårbehandlingsmidler indeholdende thromboxan A2-receptor-antagonister DK175207B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23937688 1988-09-01
US07/239,376 US4925873A (en) 1988-09-01 1988-09-01 Method of treating skin injuries using thromboxane A2 receptor antagonists

Publications (3)

Publication Number Publication Date
DK431589D0 true DK431589D0 (da) 1989-08-31
DK431589A DK431589A (da) 1990-03-02
DK175207B1 DK175207B1 (da) 2004-07-12

Family

ID=22901897

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198904315A DK175207B1 (da) 1988-09-01 1989-08-31 Sårbehandlingsmidler indeholdende thromboxan A2-receptor-antagonister

Country Status (13)

Country Link
US (1) US4925873A (da)
EP (1) EP0357030B1 (da)
JP (1) JPH02108635A (da)
AT (1) ATE100320T1 (da)
AU (1) AU632503B2 (da)
CA (1) CA1337930C (da)
DE (1) DE68912459T2 (da)
DK (1) DK175207B1 (da)
HU (1) HUT51137A (da)
IE (1) IE63799B1 (da)
NZ (1) NZ230505A (da)
PT (1) PT91597B (da)
ZA (1) ZA896558B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US5324746A (en) * 1993-02-12 1994-06-28 Mckee Rex N Method of treating damaged mucosal and epithelial tissues with misoprostol
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US7910624B1 (en) 1995-03-03 2011-03-22 The Trustees Of Boston University Compositions for the treatment of blood disorders
EP0731712A4 (en) * 1993-10-29 2005-11-09 Univ Boston PHYSIOLOGICAL STABILIZED BUTTERIC ACID PREPARATIONS, AND BUTTERIC ACIDS AND DERIVATIVES AS ANTINEOPLASTIC ACTIVE SUBSTANCE
PT1203761E (pt) 1994-10-21 2005-04-29 Nps Pharma Inc Compostos activos do receptor de calcio
GB9424708D0 (en) * 1994-12-07 1995-02-01 Bristol Myers Squibb Co Use of inflammatory modulators in the treatment of chronic or recalcitrant skin damage
US6011000A (en) * 1995-03-03 2000-01-04 Perrine; Susan P. Compositions for the treatment of blood disorders
AU731146C (en) 1996-05-01 2005-02-03 Nps Pharmaceuticals, Inc. Inorganic ion receptor-active compounds
US5994399A (en) * 1997-03-27 1999-11-30 Mckee; Rex N. Method of regenerating collagen-containing tissues with misoprostol
CA2324426A1 (en) * 1998-02-11 1999-08-19 Douglas V. Faller Compositions and methods for the treatment of cystic fibrosis
US7241746B2 (en) * 2003-08-06 2007-07-10 Regena Therapeutics, Lc Method and composition for treating periodontal disease
WO2010105112A1 (en) * 2009-03-11 2010-09-16 Hemaquest Pharmaceuticals, Inc. Detection of short-chain fatty acids in biological samples
WO2011038224A1 (en) 2009-09-24 2011-03-31 Trustees Of Boston University Methods for treating viral disorders
WO2011072086A1 (en) 2009-12-08 2011-06-16 Hemaquest Pharmaceuticals, Inc. Methods and low dose regimens for treating red blood cell disorders
US20110245154A1 (en) 2010-03-11 2011-10-06 Hemaquest Pharmaceuticals, Inc. Methods and Compositions for Treating Viral or Virally-Induced Conditions
MY178073A (en) 2011-02-02 2020-10-01 Biotropics Malaysia Berhad Cosmetic non therapeutic use of extracts from ficus deltoidea
SG11202113215UA (en) 2019-05-31 2021-12-30 Viracta Subsidiary Inc Methods of treating virally associated cancers with histone deacetylase inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2809377A1 (de) * 1978-03-04 1979-09-13 Boehringer Mannheim Gmbh Phenoxyalkylcarbonsaeure-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
US4311707A (en) * 1979-02-12 1982-01-19 American Cyanamid Company Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions
DE3000377A1 (de) * 1980-01-07 1981-07-09 Boehringer Mannheim Gmbh, 6800 Mannheim Neue sulfonamide, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
US4537981A (en) * 1981-11-09 1985-08-27 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane and 7-oxabicycloheptene compounds
US4416896A (en) * 1982-05-17 1983-11-22 E. R. Squibb & Sons, Inc. 7-Oxabicyclopheptane substituted amino prostaglandin analogs useful in the treatment of thrombolytic disease
US4663336A (en) * 1985-07-01 1987-05-05 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted diamide and its congener prostaglandin analogs useful in the treatment of thrombotic disease
US4673685A (en) * 1986-07-23 1987-06-16 E. R. Squibb & Sons, Inc. Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease
US4752616A (en) * 1987-06-29 1988-06-21 E. R. Squibb & Sons, Inc. Arylthioalkylphenyl carboxylic acids, compositions containing same and method of use

Also Published As

Publication number Publication date
HUT51137A (en) 1990-04-28
DE68912459D1 (de) 1994-03-03
PT91597B (pt) 1995-05-04
JPH02108635A (ja) 1990-04-20
IE63799B1 (en) 1995-06-14
AU4089889A (en) 1990-03-08
ZA896558B (en) 1990-05-30
DK431589A (da) 1990-03-02
DK175207B1 (da) 2004-07-12
AU632503B2 (en) 1993-01-07
DE68912459T2 (de) 1994-08-04
ATE100320T1 (de) 1994-02-15
US4925873A (en) 1990-05-15
IE892755L (en) 1990-03-01
EP0357030A2 (en) 1990-03-07
PT91597A (pt) 1990-03-30
NZ230505A (en) 1997-03-24
EP0357030A3 (en) 1990-08-16
EP0357030B1 (en) 1994-01-19
CA1337930C (en) 1996-01-16

Similar Documents

Publication Publication Date Title
DK431589A (da) Saarbehandlingsmidler indeholdende thromboxan a2-receptor-antagonister
IS4073A (is) Nýtt fjölvirknislyf gegn aukningu mótstöðu
DE68929460D1 (de) Substituierte Phenylpyrimidine Derivate, für die Behandlung oder Prevention von ZNS-Erkrankungen
IT8167845A0 (it) Composizione per il trattamento topico dell'acne
IT8147606A0 (it) Composizione per il trattamento topico dell'acne
DE59304351D1 (de) Neue therapeutische Verwendungen von Phthalazinon-Derivaten
DE58904960D1 (de) Verwendung von serotonin-antagonisten bei der behandlung von apoplexia cerebri.
DK90089D0 (da) Hudbehandlingspraeparat
IT1221826B (it) Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi
DK71387A (da) Terapeutisk middel til behandling af psoriasis
ATE194919T1 (de) Verwendung von dibutyl-adipat und isopropyl- myristat in topischen und transdermalen produkten
ES2061989T3 (es) Uso de esteres alquilicos del acido piroglutamico para la fabricacion de un medicamento para el tratamiento de la ictiosis.
ES2080736T3 (es) Uso de 2,3,4,5-tetrahidro-1h-3-benzazepinas en el tratamiento de trastornos neurologicos.
DE68906707D1 (de) 3-substituierte 2-oxindol-1-carboxamid-derivate zur hemmung der aktivitaet der t-zellen.
ATE273713T1 (de) Fas-antagonist für die prophylaxe oder therapie von gvhd
DE68912376D1 (de) Analoge von Bradykinin, dessen Synthese und dessen Benutzung in der Therapie.
ATE173263T1 (de) Imidazolochinoxalinonderivate als eaa antagonisten
FI891473A (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-aryyli-4-piperidiinikarbinolien valmistamiseksi
ES2070148T3 (es) Derivado de la glicerina y utilizacion farmacologica del mismo.
DK277387D0 (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
IT1209547B (it) Composizione farmaceutica per il trattamento dell'aritmia e relativo processo antiaritmico.
ITMI912224A1 (it) Impiego di composti adenosinici nel trattamento dell'ischemia
MX9203362A (es) Composicion diuretica de benazepril/tiazida de dosis baja, para el tratamiento de la hipertension
DE59305285D1 (de) Transdermales therapeutisches system mit pentylentetrazol als wirkstoff
DE69806098D1 (de) yerwendung von einer 2-aroyl-3-arylbenzo(b)thiophen Verbindung zur Senkung des Fibrinogens

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK